EUVIMEDEUVIMED entdecken
Crossref

Genetic variety of ORF3a shapes SARS‐CoV‐2 fitness through modulation of lipid droplet

Weili Wang, Yafei Qu, Xin Wang, Maggie Z X Xiao, Joyce Fu, Lei Chen, Yuejuan Zheng, Qiming Liang iD

Journal of Medical Virology · 2023

DOI: 10.1002/jmv.28630 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Weili Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Immune-Related Diseases at Shanghai Institute of Immunology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, …. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Severe acute respiratory syndrome-related coronavirus. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) infection leads to the accumulation of lipid droplets (LD), the central hubs of the lipid metabolism, in vitro or in type II pneumocytes and monocytes from coronavirus disease 19 (COVID‐19) patients and blockage of LD formation by specific inhibitors impedes SARS‐CoV‐2 replication. Here, we showed that ORF3a is necessary and sufficient to trigger LD accumulation during SARS‐CoV‐2 infection, leading to efficient virus replication. Although highly mutated during evolution, ORF3a‐mediated LD modulation is conserved in most SARS‐CoV‐2 variants except the Beta strain and is a major difference between SARS‐CoV and SARS‐CoV‐2 that depends on the genetic variations on the amino acid position 171, 193, and 219 of ORF3a. Importantly, T223I substitution in recent Omicron strains (BA.2‐BF.8) impairs ORF3a‐Vps39 association and LD accumulation, leading to less efficient replication and potentially contributing to lower pathogenesis of the Omicron strains. Our work characterized how SARS‐CoV‐2 modulates cellular lipid homeostasis to benefit its replication during virus evolution, making ORF3a‐LD axis a promising drug target for the treatment of COVID‐19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2Severe acute respiratory syndrome-related coronavirusHumansLipid DropletsViroporin Proteins

Stichwörter der Autor:innen

ORF3aSARS-CoV-2autophagylipid droplet

Substanzen

ORF3a protein, SARS-CoV-2Viroporin Proteins

Autor:innen und Institutionen

  • Center for Immune-Related Diseases at Shanghai Institute of Immunology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Immunology and Microbiology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Faculty of Medicine, University of Alberta, Edmonton, Alberta, Canada.
  • Department of Statistics, University of California, Riverside, Riverside, California, USA.
  • Shanghai Institute of Immunology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • The Research Center for Traditional Chinese Medicine, Shanghai Institute of Infectious Disease and Biosecurity, Shanghai University of Traditional Medicine, Shanghai, China.

ORCID-Profile: Qiming Liang

Zitieren

APA

Wang, W., Qu, Y., Wang, X., Xiao, M. Z. X., Fu, J., Chen, L., Zheng, Y., & Liang, Q. (2023). Genetic variety of ORF3a shapes SARS‐CoV‐2 fitness through modulation of lipid droplet. Journal of Medical Virology. https://doi.org/10.1002/jmv.28630

Vancouver

Wang W, Qu Y, Wang X, Xiao MZX, Fu J, Chen L, et al. Genetic variety of ORF3a shapes SARS‐CoV‐2 fitness through modulation of lipid droplet. Journal of Medical Virology. 2023. doi:10.1002/jmv.28630

BibTeX
@article{Wang2023,
  author = {Wang, Weili and Qu, Yafei and Wang, Xin and Xiao, Maggie Z X and Fu, Joyce and Chen, Lei and Zheng, Yuejuan and Liang, Qiming},
  title = {Genetic variety of ORF3a shapes SARS‐CoV‐2 fitness through modulation of lipid droplet},
  journal = {Journal of Medical Virology},
  year = {2023},
  doi = {10.1002/jmv.28630}
}
Kostenlos starten →